fbxl15 Antibody

What is FBXL15 and what cellular functions does it regulate?

FBXL15 (F-box and leucine-rich repeat protein 15, also known as FBXO37) is a component of the SCF (Skp1-Cullin1-F-box) ubiquitin ligase complex that plays critical roles in protein degradation pathways. The protein contains an F-box domain (amino acids 22-64) in its N-terminus and six leucine-rich repeat (LRR) domains (amino acids 113-269) distributed across the remaining regions .

FBXL15 functions primarily in:

• Positive regulation of BMP (bone morphogenetic protein) signaling pathway

• G2/M transition of the cell cycle

• Cellular protein metabolic processes, particularly through ubiquitination mechanisms

• Embryonic development and bone formation

Mechanistically, FBXL15 recognizes specific phosphorylated proteins and promotes their ubiquitination and subsequent proteasomal degradation . A well-characterized target is Smurf1, whose degradation by FBXL15 results in enhanced BMP signaling .

What is the molecular structure and cellular localization of FBXL15?

FBXL15 has a calculated molecular weight of 33 kDa (300 amino acids) and typically appears at this weight on Western blots . Structurally, the protein comprises:

Regarding localization, immunofluorescence studies show that FBXL15 is predominantly cytoplasmic, where it colocalizes with its substrates such as Smurf1 . Expression analysis reveals that FBXL15 is widely distributed across tissues, including heart, liver, spleen, bone, muscle, brain, and kidney, as well as various human cell lines .

What applications are validated for FBXL15 antibodies?

Based on commercial antibody validation data, FBXL15 antibodies have been successfully used in:

When performing IHC, antigen retrieval with TE buffer (pH 9.0) is suggested, although citrate buffer (pH 6.0) can serve as an alternative .

How should researchers optimize FBXL15 antibody use in experimental protocols?

For optimal results when using FBXL15 antibodies:

• Western Blotting:

  • Follow specific WB protocols provided by manufacturers, as these are antibody-dependent

  • When analyzing FBXL15-Smurf1 interactions, consider using co-immunoprecipitation followed by immunoblotting

  • For degradation studies, treat samples with proteasome inhibitors (e.g., MG132) to stabilize proteins targeted for degradation

• Immunohistochemistry:

  • Antigen retrieval is critical - use TE buffer (pH 9.0) for optimal epitope exposure

  • Optimize antibody concentration through titration experiments (starting with the 1:50-1:500 range)

  • Include appropriate positive controls (e.g., human breast cancer tissue)

• Storage and Handling:

  • Store antibodies at -20°C

  • Aliquoting is generally unnecessary for -20°C storage

  • Working solutions should contain PBS with 0.02% sodium azide and 50% glycerol at pH 7.3

How can FBXL15 antibodies be used to study SCF complex formation and function?

To investigate FBXL15's participation in the SCF complex:

• Co-immunoprecipitation strategy:

  • Immunoprecipitate FBXL15 using validated antibodies

  • Probe for associated SCF components (Cullin1, Skp1, and Roc1) via Western blotting

  • Compare wild-type FBXL15 with F-box deletion mutants (ΔF) to confirm F-box-dependent interactions

• Proximity Ligation Assays to visualize FBXL15-SCF component interactions in situ

• siRNA depletion experiments:

  • Use two independent siRNA duplexes targeting FBXL15, Cullin1, or Roc1

  • Monitor effects on target protein stability (e.g., Smurf1)

  • Include siRNA-resistant FBXL15 mutants for rescue experiments to confirm specificity

What methods are most effective for studying FBXL15-mediated ubiquitination?

To study FBXL15's role in ubiquitination processes:

• In vivo ubiquitination assays:

  • Co-transfect cells with HA-ubiquitin, FBXL15, and substrate protein (e.g., Smurf1)

  • Treat with proteasome inhibitors (MG132) before lysis

  • Immunoprecipitate the substrate protein

  • Immunoblot with anti-HA antibodies to detect ubiquitinated species

• In vitro ubiquitination assays:

  • Purify FBXL15 from cultured cells

  • Combine with purified substrate, E1, E2 (UbcH5c or UbcH7), and ubiquitin

  • Incubate and analyze ubiquitination by immunoblotting

• Mapping ubiquitination sites:

  • Generate lysine-to-arginine mutants of substrate proteins

  • Compare ubiquitination patterns and degradation rates

  • The K355+357R double mutation in Smurf1 provides a valuable negative control as it abrogates FBXL15-mediated ubiquitination

How can researchers use FBXL15 antibodies to investigate its role in BMP signaling and bone formation?

To explore FBXL15's function in BMP signaling:

• Analysis of BMP pathway components:

  • Monitor phosphorylation of Smad1/5/8 after FBXL15 manipulation

  • Examine BMP target gene expression through qPCR or reporter assays

  • Correlate with Smurf1 protein levels

• In vivo bone formation studies:

  • Inject FBXL15 siRNAs into rat bone tissues to assess effects on bone mass

  • Measure bone mineral density using micro-CT

  • Perform histological analysis of bone morphology

  • Use FBXL15 antibodies for immunohistochemical detection in bone samples

• Developmental studies:

  • Analyze embryonic phenotypes after knockdown of FBXL15 in model organisms

  • The zebrafish model is particularly valuable as knockdown of fbxl15 causes embryonic dorsalization similar to BMP-deficient mutants

What are common issues when using FBXL15 antibodies and how can they be addressed?

How can researchers validate FBXL15 antibody specificity?

To ensure antibody specificity:

• Genetic knockdown validation:

  • Perform siRNA-mediated knockdown of FBXL15

  • Western blot analysis should show diminished signal at 33 kDa

  • Include rescue experiments with siRNA-resistant FBXL15 constructs

• Overexpression controls:

  • Transfect cells with FBXL15 expression constructs

  • Compare band intensity and molecular weight with endogenous protein

• Peptide competition assays:

  • Pre-incubate antibody with the immunizing peptide

  • This should abolish specific signal in applications like WB and IHC

What experimental considerations are important when studying FBXL15-substrate interactions?

When investigating FBXL15-substrate relationships:

• Domain mapping:

  • The LRR domains of FBXL15 are critical for substrate recognition

  • For Smurf1 interaction, focus on the large subdomain of the HECT domain N-lobe

• Protein stability assessments:

  • Perform cycloheximide chase assays to measure half-life of putative substrates

  • Compare stability in control versus FBXL15-depleted or overexpressing conditions

  • Remember that proteins may be targeted by multiple degradation pathways (e.g., Smurf1 undergoes both FBXL15-mediated degradation and auto-degradation)

• Interaction verification:

  • Confirm physiological interactions using antibodies against endogenous proteins

  • Include appropriate negative controls (pre-immune IgG)

  • Verify colocalization through immunofluorescence microscopy